|
|
|
|
|
Teisinis statusas
Patentas galioja
| (51) | INT.CL. | C07D 487/04 | (2006.01) |
| A61K 31/4985 | (2006.01) | ||
| A61P 37/02 | (2006.01) | ||
| A61P 29/00 | (2006.01) | ||
| A61P 25/28 | (2006.01) |
| (11) | Patento numeris | 3419978 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17705705.6 |
| Europos patento paraiškos padavimo data | 2017-02-10 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-01-02 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-04-15 |
| (46) | Apibrėžties vertimo paskelbimo data | 2020-06-10 |
| (86) | Numeris | PCT/IB2017/050748 |
| Data | 2017-02-10 |
| (87) | Numeris | WO 2017/144995 |
| Data | 2017-08-31 |
| (30) | Numeris | Data | Šalis |
| 201662299130 P | 2016-02-24 | US |
| (72) |
BROWN, Matthew Frank, US
DERMENCI, Alpay, US
FENSOME, Andrew, US
GERSTENBERGER, Brian Stephen, US
HAYWARD, Matthew Merrill, US
OWEN, Dafydd Rhys, US
WRIGHT, Stephen Wayne, US
XING, Li Huang, US
YANG, Xiaojing, US
|
| (73) |
Pfizer Inc.,
235 East 42nd Street, New York, NY 10017,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Pirazolo[1,5-a]pirazin-4-ilo dariniai, kaip JAK inhibitoriai |
| PYRAZOLO[1,5-A]PYRAZIN-4-YL DERIVATIVES AS JAK-INHIBITORS |
| Mokėjimo data | Galiojimo metai | Suma | |
| 2026-01-26 | 10 | 231.00 EUR |
| 2027-02-10 |